Geiger Ann M, Buist Diana S M, Greene Sarah M, Altschuler Andrea, Field Terry S
Division of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157, USA.
Cancer. 2008 Jun 1;112(11 Suppl):2617-26. doi: 10.1002/cncr.23447.
Integrated healthcare delivery systems present unique opportunities for cancer survivorship research. The National Cancer Institute funds the Cancer Research Network (CRN) to leverage these capabilities for all types of cancer research, including survivorship.
The authors gathered information from a recent CRN funding application, Survivorship Interest Group materials, the CRN website, and published articles. CRN studies were selected to illustrate diverse topics and a variety of data-collection approaches.
The 14 systems that participate in the CRN provide care for approximately 10.8 million individuals of all ages and racial/ethnic backgrounds, for whom approximately 38,000 new cancer diagnoses were made in 2005. CRN systems have the ability to use existing data and collect new data on patients, providers, and organizations through well established research centers staffed by independent scientists. Of the 45 funded and 2 pending CRN grant applications as of November 30, 2007, 21 include aspects related to cancer survivorship. These studies have examined clinical trial participation, patterns of care, age and racial/ethnic disparities, diffusion of clinical trial findings, treatment outcomes, surveillance, and end-of-life and palliative care. Breast, colorectal, lung, ovarian, and prostate cancers have been the focus of these studies. Results of these studies have been published widely in leading journals.
Completed and ongoing CRN survivorship studies provide a strong foundation for future studies. Scientists from all institutional affiliations are welcome to approach the CRN with ideas and are encouraged to allow ample time to establish collaborative relationships and design rigorous studies.
整合式医疗服务体系为癌症幸存者研究提供了独特机遇。美国国立癌症研究所资助癌症研究网络(CRN),以利用这些能力开展各类癌症研究,包括幸存者研究。
作者从CRN近期的资助申请、幸存者兴趣小组资料、CRN网站及已发表文章中收集信息。选取CRN研究以说明不同主题及多种数据收集方法。
参与CRN的14个系统为约1080万各年龄段及种族/族裔背景的个体提供医疗服务,2005年这些个体中有约38000例新发癌症诊断。CRN系统有能力利用现有数据,并通过由独立科学家组成的成熟研究中心收集关于患者、医疗服务提供者及机构的新数据。截至2007年11月30日,在45项已获资助及2项待批的CRN资助申请中,21项包含与癌症幸存者相关的方面。这些研究考察了临床试验参与情况、护理模式、年龄及种族/族裔差异、临床试验结果的传播、治疗结局、监测以及临终和姑息治疗。乳腺癌、结直肠癌、肺癌、卵巢癌和前列腺癌一直是这些研究的重点。这些研究结果已在主流期刊上广泛发表。
已完成及正在进行的CRN幸存者研究为未来研究奠定了坚实基础。欢迎所有机构的科学家带着想法与CRN接洽,并鼓励留出充足时间建立合作关系及设计严谨的研究。